358 related articles for article (PubMed ID: 33949198)
1. Absorption of nonheme iron during gastric acid suppression in patients with hereditary hemochromatosis and healthy controls.
Moris W; Verhaegh PLM; Verbeek J; Swinkels DW; Laarakkers CM; Masclee AAM; Koek GH; Deursen CTBMV
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1105-G1110. PubMed ID: 33949198
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis.
van Aerts RM; van Deursen CT; Koek GH
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):147-52. PubMed ID: 26240005
[TBL] [Abstract][Full Text] [Related]
3. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.
Hutchinson C; Geissler CA; Powell JJ; Bomford A
Gut; 2007 Sep; 56(9):1291-5. PubMed ID: 17344278
[TBL] [Abstract][Full Text] [Related]
5. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial.
Vanclooster A; van Deursen C; Jaspers R; Cassiman D; Koek G
Gastroenterology; 2017 Sep; 153(3):678-680.e2. PubMed ID: 28624580
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.
Daher R; Kannengiesser C; Houamel D; Lefebvre T; Bardou-Jacquet E; Ducrot N; de Kerguenec C; Jouanolle AM; Robreau AM; Oudin C; Le Gac G; Moulouel B; Loustaud-Ratti V; Bedossa P; Valla D; Gouya L; Beaumont C; Brissot P; Puy H; Karim Z; Tchernitchko D
Gastroenterology; 2016 Mar; 150(3):672-683.e4. PubMed ID: 26582087
[TBL] [Abstract][Full Text] [Related]
10. The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis.
Verhaegh PL; Moris W; Koek GH; van Deursen CT
Liver Int; 2016 Oct; 36(10):1535-9. PubMed ID: 26992127
[TBL] [Abstract][Full Text] [Related]
11. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
[TBL] [Abstract][Full Text] [Related]
12. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
13. Hemochromatosis and pregnancy: iron stores in the Hfe-/- mouse are not reduced by multiple pregnancies.
Neves JV; Olsson IA; Porto G; Rodrigues PN
Am J Physiol Gastrointest Liver Physiol; 2010 Apr; 298(4):G525-9. PubMed ID: 20110460
[TBL] [Abstract][Full Text] [Related]
14. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis.
Ryan JD; Ryan E; Fabre A; Lawless MW; Crowe J
Hepatology; 2010 Oct; 52(4):1266-73. PubMed ID: 20658468
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
[TBL] [Abstract][Full Text] [Related]
16. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
[TBL] [Abstract][Full Text] [Related]
17. Screening for iron overload in the Turkish population.
Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron.
Gehrke SG; Kulaksiz H; Herrmann T; Riedel HD; Bents K; Veltkamp C; Stremmel W
Blood; 2003 Jul; 102(1):371-6. PubMed ID: 12637325
[TBL] [Abstract][Full Text] [Related]
19. Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: a systematic review.
Moretti D; van Doorn GM; Swinkels DW; Melse-Boonstra A
Am J Clin Nutr; 2013 Aug; 98(2):468-79. PubMed ID: 23803887
[TBL] [Abstract][Full Text] [Related]
20. Small Molecule Inhibitors of NFkB Reverse Iron Overload and Hepcidin Deregulation in a Zebrafish Model for Hereditary Hemochromatosis Type 3.
Basu S; Jalodia K; Ranjan S; Yeh JJ; Peterson RT; Sachidanandan C
ACS Chem Biol; 2018 Aug; 13(8):2143-2152. PubMed ID: 29897731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
